Mittal Nitish, Mittal Rohan, Ramon Mikal C, Sly Zhaunn, Ansari Mohammad M
Internal Medicine/Cardiology, Texas Tech University Health Sciences Center, Lubbock, USA.
Cureus. 2022 Feb 16;14(2):e22283. doi: 10.7759/cureus.22283. eCollection 2022 Feb.
The AngioVac system (AngioDynamics Inc., Latham, NY) is used for the removal of commonly encountered intravascular material, such as thrombus or vegetations in the right atrium, right ventricle, superior vena cava, and inferior vena cava. Patients with high surgical risk having tricuspid endocarditis and superior vena cava thrombus can be treated with the AngioVac system, hence mitigating the risks for this patient population. We present a case series with the utilization of the AngioVac device to reduce the vegetation size and decrease the risk of emboli with effective antibiotic penetration. Transesophageal echocardiography shows a reduction in the size of the vegetations in all three cases with no postoperative complications. This case series demonstrates a novel technique debulking vegetations in tricuspid endocarditis and vena cava.
AngioVac系统（AngioDynamics公司，纽约州拉瑟姆）用于清除常见的血管内物质，如右心房、右心室、上腔静脉和下腔静脉中的血栓或赘生物。患有三尖瓣心内膜炎和上腔静脉血栓且手术风险高的患者可用AngioVac系统治疗，从而降低该患者群体的风险。我们展示了一个病例系列，利用AngioVac装置减小赘生物大小并降低栓塞风险，同时实现有效的抗生素渗透。经食管超声心动图显示，所有三例患者的赘生物大小均减小，且无术后并发症。该病例系列展示了一种用于减小三尖瓣心内膜炎和腔静脉赘生物体积的新技术。
